Behrman acquires unit from Elan
US private equity house Behrman Capital has paid $122m for the lab testing services division of Irish pharmaceutical business Elan Corp.
30 December 2012•2 mins read
US private equity house Behrman Capital has paid $122m for the lab testing services division of Irish pharmaceutical business Elan Corp.
Side Letter: Markdowns, moratoriums
5 November 2026 · 2 mins read
AllianzGI leaves door open for reversal of PE pullback
5 November 2026 · 2 mins read
How Schroders’ $30bn PE funds platform is growing its CV and co-invest allocations
5 November 2026 · 4 mins read
Side Letter: Johns, jitters, judgment calls
4 November 2026 · 5 mins read
Rothschild & Co’s private client unit seeks to rebalance PE portfolio
4 November 2026 · 2 mins read
Weil wind-down: How fund mandates will be affected
4 November 2026 · 4 mins read
Side Letter: Blended buyouts
3 November 2026 · 3 mins read
